{"id":"W2561489460","doi":"10.1182/blood.v114.22.644.644","title":"Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patients Who Harbor the Bcr- Abl T315I Mutation–Results of An Ongoing Multicenter Phase 2/3 Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Imatinib; Imatinib mesylate; Dasatinib; Adverse effect; Gastroenterology; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005144778,0.0004080599,0.0008795108,0.0002168585,0.0001104988,0.00002579591,0.0003080328,0.0001163847,0.00003842968],"category_scores_gemma":[0.0005753536,0.0003022841,0.0001198934,0.0003687845,0.0001305711,0.000160257,0.00009373613,0.0002900587,0.000004292601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007271353,"about_ca_system_score_gemma":0.0005171249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003475974,"about_ca_topic_score_gemma":0.0003749253,"domain_scores_codex":[0.9966094,0.0002488099,0.001430627,0.0006256896,0.0006098574,0.0004756061],"domain_scores_gemma":[0.9974892,0.0003619658,0.0006745206,0.001074712,0.0002049692,0.0001946055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2226116,0.1616048,0.06089028,0.002920589,0.005145335,0.007269511,0.05010684,0.0008978044,0.1679007,0.0001392658,0.0001533186,0.32036],"study_design_scores_gemma":[0.2743098,0.02646059,0.657894,0.0009160322,0.001150343,0.00009220728,0.0006332268,0.002997757,0.03504014,0.0000104345,0.000104428,0.0003911115],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960198,0.0005114698,0.000004068213,0.0001877165,0.00005115497,0.002601196,0.0002004863,0.00004096427,0.0003831219],"genre_scores_gemma":[0.9988949,0.00009198495,0.0005699408,0.00006219747,0.00005916212,0.00002495535,0.0001515974,0.00004201501,0.0001032685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5970036,"threshold_uncertainty_score":0.9999429,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01030782127058177,"score_gpt":0.2801597147102233,"score_spread":0.2698518934396416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}